Form 4: Femasys COO Granted 150,000 Stock Options

Femasys Inc.'s Chief Operating Officer, John Charles Canning, was granted 150,000 stock options with an exercise price of $0.38, vesting over four years.

Summary

• John Charles Canning, Chief Operating Officer of Femasys Inc. (FEMY), was granted 150,000 stock options.
• The options have an exercise price of $0.38 per share.
• The transaction date for the grant was March 30, 2026.
• The options begin vesting on March 30, 2027, and will vest equally in installments over a four-year period.
• The expiration date for these options is March 30, 2036.
• Vesting is contingent upon Mr. Canning's continued employment with Femasys or its subsidiaries.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, reflecting standard executive compensation practices designed to align management incentives with long-term shareholder value. It's not a major catalyst but indicates stability in executive retention strategy.

Positives

• The grant of stock options aligns the Chief Operating Officer's long-term interests with those of shareholders.
• The options provide a performance incentive for the COO to contribute to the company's growth and share price appreciation.

Negatives

• No direct negative financial implications are reported in this Form 4 filing.

Risks

• The vesting of the stock options is conditional on the reporting person's continued employment with Femasys Inc. or a subsidiary on each vesting date.

Future Outlook

The stock option grant indicates a long-term commitment to the Chief Operating Officer and aims to incentivize future performance and alignment with shareholder value creation over the next decade, contingent on continued employment.

Industry Context

StockSavvy.ai notes that granting stock options to key executives like a Chief Operating Officer is a standard practice across industries. This strategy is widely used to align management's financial incentives with the long-term performance of the company and shareholder interests, fostering retention and motivation.

Comparison to Industry Standards

• Executive stock option grants are a common component of compensation packages for senior management in publicly traded companies, particularly in growth-oriented sectors.
• The four-year vesting schedule is typical for such grants, similar to practices observed at companies like Moderna (MRNA) for R&D executives or Salesforce (CRM) for senior leadership, aiming to ensure long-term commitment.
• The exercise price of $0.38, which appears to be the market price at the time of grant, is standard for incentive stock options, ensuring the executive benefits only if the stock price appreciates.

Related Party Transactions

• The grant of 150,000 stock options to John Charles Canning, the Chief Operating Officer, constitutes a related party transaction as it involves an executive of the company.

Stakeholder Impact

• Shareholders: Potential positive impact through improved alignment of executive incentives with long-term company performance and shareholder value creation.
• Employees (COO): Direct positive impact on compensation and long-term wealth creation potential, contingent on company performance and continued employment.

Next Steps

• The stock options will begin vesting in equal installments over four years starting March 30, 2027.
• The Chief Operating Officer must remain employed by Femasys Inc. or a subsidiary for the options to vest.

Key Dates

Keywords

Femasys, FEMY, Stock Option, Executive Compensation, Insider Transaction, Form 4, John Charles Canning, Chief Operating Officer, Equity Grant